British Business Bank

Activity from announced rounds

Activity in this selectionAI

British Business Bank is the UK’s economic development bank, supporting business access to finance through investment programmes, funds and financing partners.

Its Future Fund: Breakthrough programme, delivered by British Patient Capital, co-invests with private investors in later-stage, R&D-intensive UK companies. It targets technologies such as quantum computing, cleantech and life sciences, where development requires substantial capital.

Applications to that programme come from a qualifying sponsor investor, rather than directly from the company. The published criteria require a round of at least £30 million, with the programme contributing no more than 30% on the sponsor investor’s terms.

Sources
Rounds participated in
7
Confirmed lead rounds
0
6 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$1.7B
6 disclosed · full round size, not this investor’s share

By stage

Series C+2
Undisclosed2
Seed1
Series A1
Series B1

By primary sector

Biotech2
AI1
Climate tech1
Defense tech1
Hardware1
1 more
Healthtech1

By country

United Kingdom7

Rounds

7 in this selection
Salience Labs

Salience Labs develops silicon photonic switches for datacenter operators connecting large AI computing clusters.

$125MSeries B
Participant
IMU Biosciences

Profiles human immune systems using multi-omic analysis and machine learning for disease research.

$53MSeries A
Role not disclosed
Hadean

Develops AI-powered digital wargaming and command-and-control capabilities.

UndisclosedUndisclosed
Role not disclosed
Wayve

Provides end-to-end AI platform for autonomous driving licensed to automakers and mobility platforms

$1.5BSeries D
Role not disclosed
Pontiro

Enables safe and compliant use of medical imaging data for research and AI

£357KSeed
Role not disclosed
Kraken Technologies

Kraken leverages AI to automate customer service and billing for energy firms

£25MUndisclosed
Role not disclosed
Nuclera

Provides rapid access to functional proteins through benchtop eProtein Discovery System

$12MSeries C+
Role not disclosed